Patient Square Capital is set to acquire Premier, a technology-powered healthcare improvement company, in a deal valued at $2.6bn. Premier’s board of directors unanimously approved the agreement. The company's shareholders will receive $28.25 per share in cash, reflecting a premium of 23.8% to its 60-day volume-weighted average price. Premier president and CEO Michael Alkire said: "Since going public in 2013, Premier has leveraged our access to capital to build unmatched supply chain expertise, world-c ...